You are here

Industry News

Advamed Smart Brief

April 24, 2018
An agreement was reached by Orion to sell its diagnostics business, Orion Diagnostica, to an Axcel Management-led investment  -More
April 24, 2018
Terumo subsidiaries Vascutek and Bolton Medical will merge to become Terumo Aortic, a company that will offer surgical grafts -More
April 24, 2018
The acquisition of Minnetonka, Minn.-based Cogentix Medical, valued at $214 million, was completed by Toronto-based Laborie M -More
April 24, 2018
An initial public offering of 5 million shares was priced by Maple Grove, Minn.-based Inspire Medical Systems at a price rang -More
April 24, 2018
A round of Series A financing pulled in $11 million for Cambridge, Mass.-based NuProbe, an early-stage molecular diagnostics  -More
April 24, 2018
A round of equity financing involving 16 unnamed sources brought in $7 million for Newton, Mass.-based Cheetah Medical, a reg -More
April 24, 2018
Integrating data into the care process holds a great deal of promise for the health care industry.  -More
April 24, 2018
A clinical trial collaboration agreement in the US, Canada and Europe between Medtronic and Arca Biopharma was extended until -More
April 24, 2018
Viz.ai secured 510(k) clearance from the FDA for its Viz CTP automated image-processing software, which allows for viewing of -More
April 24, 2018
The FDA granted Medtronic approval for its IN.PACT Admiral drug-coated balloon for use in the treatment of superficial femora -More

Industry News

Helius Medical Technologies, Inc.
NEWTOWN, PA.,  April 11, 2018 - Helius Medical Technologies, Inc. (“Helius” or the “Company”) today announced the pricing of an underwritten public offering of 2,141,900 shares of its Class A common stock and warrants to purchase 2,141,900 shares of its Class A common stock at a public offering price of US$7.47 per share and accompanying warrant, before underwriting discounts and commissions.  The net proceeds to the Company from this offering, after deducting the underwriting discounts,...
PR Newswire
California-based Myoscience, Inc. announced today that it received 510k clearance from the US FDA for Smart Tip with Nerve Stim, the latest innovative tip for Myoscience’s iovera° platform technology. With the FDA clearance for Smart Tip with Nerve Stim, physicians will be able to stimulate a nerve in advance of delivering iovera° cold therapy to the treatment area, reducing patient treatment times. Additionally, the use of Smart Tip with Nerve Stim enables physicians using iovera° to access...
Media Planet
It sometimes strikes without warning. People of any age, race, ethnicity and gender are at risk. In fact, it is the leading killer of both men and women in America. It is heart disease, and each year it claims the lives of over 600,000 Americans, accounting for one-quarter of all deaths in the United States. 
Boston Scientific
Boston Scientific commends the efforts of key champions in the U.S. House and Senate for their successful efforts to suspend the medical device tax, allowing the device industry to reinvest in work to benefit patients.
Sysmex America
LINCOLNSHIRE, ILL. – Nov. 8, 2017 – Sysmex America announced today that its Sysmex XW-100 received clearance from the U.S. Food and Drug Administration (FDA)—making it the first Clinical Laboratory Improvement Amendments (CLIA)-waived, complete blood count (CBC) system. Once prepared for each day’s use, the XW-100 will allow health care professionals to provide patients with blood test results in as few as three minutes.